VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Valneva SE

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 17, 2026

$5.51−0.10 (-1.78%)

Close on Oct 19, 2026

Fundamental chart

Pick a measure to chart its full history

€174.66MFY2025, +5.6% a year since FY2019

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is VALN.

Revenue growth-27.2% · median 30.5%

Gross margin16.4% · median 89.1%

Operating margin-80.5% · median -56.6%

Advertisement
300 × 250